Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-118360

SVP, Chief Scientific Officer sold 25,000 shares at $4.97 ($124,250)

  • SVP, Chief Scientific Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Abrahmsen Lars B. SVP, Chief Scientific Officer 2021-09-20 Option exercise +25,000 $0.92 $23,000 44,000 D
Abrahmsen Lars B. SVP, Chief Scientific Officer 2021-09-20 Sale −25,000 $4.97 $124,250 19,000 D
Derivatives
Abrahmsen Lars B. SVP, Chief Scientific Officer 2021-09-20 Option exercise · Stock Option (right to Buy) −25,000 80,587 D
Open-market sales · 25,000 sh · avg $4.97 · $124,250
Loading xslF345X03/tm2127534-3_4seq1.xml…